Abstract 4661: Expression of the ferroptosis suppressor FSP1 but not GPX4 shows significant adverse prognostic effect in diffuse large B-cell lymphoma with wild-type TP53
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Beibei Lyu, Zijun Xu-Monette, Xiaoxian X. Zhao, Eric D. Hsi, Ming Chen, Carlo Visco, Alexandar Tzankov, Karen Dybkaer, Mu-En Wang, Chang Wang, Qingyan Au, Harry Nunns, Zenggang Pan, Benjamin Parsons, Santiago Montes-Moreno, Fenghuang Zhan, Michael B. Møller, Leon Bernal-Mizrachi, Youli Zu, Shanxiang Zhang, Weina Chen, Govind Bhagat, Yong Li, KEN H. YOUNG
Institutions: Duke University, Duke Medical Center, Wake Forest University Health Sciences, Wake Forest University, Mayo Clinic, University of Verona, University Hospital of Basel, Aalborg University Hospital, NeoGenomics (United States), University of Colorado Anschutz, Gundersen Lutheran Hospital, Marqués de Valdecilla University Hospital, Instituto de Investigación Marqués de Valdecilla, Odense University Hospital, Houston Methodist, Cornell University, The University of Texas Southwestern Medical Center, Columbia University Irving Medical Center, Baylor College of Medicine
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148682219
Cites:
Cited by:
Related to:
